Edwards Lifesciences @EdwardsLifesci · 16 Nov 2023
Celebrating the 1M patients who have been treated with the Edwards SAPIEN transcatheter heart valve. Heart valve disease is expected to double by 2050, and with dramatic advances in innovation in the last decade, millions more can benefit from TAVR. https://t.co/w5rRUFeSbg ⚠️ https://t.co/HPmZpa3Qkw
8 102Views
28Likes
6Reposts
2Replies
0Quotes
1Bookmarks
Is that a lot?
2.95×vs 10K–100K median2 751 views is typical
73.52%Reachviews ÷ followers
0.44%Engagement rateof viewers reacted